0001683168-23-007492.txt : 20231030 0001683168-23-007492.hdr.sgml : 20231030 20231030153431 ACCESSION NUMBER: 0001683168-23-007492 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231030 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20231030 DATE AS OF CHANGE: 20231030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medicale Corp. CENTRAL INDEX KEY: 0001827855 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 981556944 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-250025 FILM NUMBER: 231359958 BUSINESS ADDRESS: STREET 1: 9314 FOREST HILL BLVD STREET 2: #929 CITY: WELLINGTON STATE: FL ZIP: 33411 BUSINESS PHONE: 407-245-7339 MAIL ADDRESS: STREET 1: 9314 FOREST HILL BLVD STREET 2: #929 CITY: WELLINGTON STATE: FL ZIP: 33411 8-K 1 medicale_8k.htm CURRENT REPORT
0001827855 false 0001827855 2023-10-30 2023-10-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 30, 2023

 

MEDICALE CORP.

(Exact name of registrant as specified in its charter)

 

Nevada   333-250025   98-1556944

(State or other jurisdiction

of incorporation)

   (Commission File Number)  

(IRS Employer

Identification No.)

 

9314 Forest Hill Blvd #929

Wellington, FL 33411

(Address of Principal Executive Offices)


 

(407) 245-7339

Registrant’s telephone number, including area code

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
None   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

 

 

 

   

 

 

Item 7.01 Regulation FD Disclosure

 

Medicale Corp (the “Company”) reports that it has entered the artificial intelligence space with the purchase and launch of the websites www.GptAIOnlineApps.com and www.GptAiApps.biz.

 

GptAIOnlineApps is a platform that allows subscribers to deploy chatbots to help manage customer engagement, lead qualification and appointment bookings. Subscribers are also able to use GptAiOnlineApps’ API backbone to integrate the chatbots on a wide range of sites such as Shopify, Squarespace and Wordpress. GptAiApps is an AI assisted content generator which helps to create unique ideas for content across different platforms such as TikTok, YouTube and Instagram based on keywords and prompts.

 

The Company intends to develop more artificial intelligence powered platforms under the “GptAI” branding that will help consumers optimize their online experience.

 

 

 

 

 

 

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Medicale Corp.  
     
     
Date: October 30, 2023 By: /s/ J. Chen Zu De                                    
  Name: Chen Zu De  
  Title: Chief Executive Officer

Chief Financial Officer

  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 3 

 

 EX-101.SCH 2 none-20231030.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 none-20231030_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 4 none-20231030_pre.xml XBRL PRESENTATION FILE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Oct. 30, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 30, 2023
Entity File Number 333-250025
Entity Registrant Name MEDICALE CORP.
Entity Central Index Key 0001827855
Entity Tax Identification Number 98-1556944
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 9314 Forest Hill Blvd
Entity Address, Address Line Two #929
Entity Address, City or Town Wellington
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33411
City Area Code (407)
Local Phone Number 245-7339
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period true
XML 6 medicale_8k_htm.xml IDEA: XBRL DOCUMENT 0001827855 2023-10-30 2023-10-30 iso4217:USD shares iso4217:USD shares 0001827855 false 8-K 2023-10-30 MEDICALE CORP. NV 333-250025 98-1556944 9314 Forest Hill Blvd #929 Wellington FL 33411 (407) 245-7339 false false false false true true EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 21 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://medicalecorp.com/role/Cover Cover Cover 1 false false All Reports Book All Reports medicale_8k.htm none-20231030.xsd none-20231030_lab.xml none-20231030_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "medicale_8k.htm": { "nsprefix": "none", "nsuri": "http://medicalecorp.com/20231030", "dts": { "inline": { "local": [ "medicale_8k.htm" ] }, "schema": { "local": [ "none-20231030.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "none-20231030_lab.xml" ] }, "presentationLink": { "local": [ "none-20231030_pre.xml" ] } }, "keyStandard": 21, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 21 }, "report": { "R1": { "role": "http://medicalecorp.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-10-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "medicale_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-10-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "medicale_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://medicalecorp.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0001683168-23-007492-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-23-007492-xbrl.zip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end